Literature DB >> 10514210

Evaluating and improving health-related quality of life in patients with varicose veins.

J J Smith1, A M Garratt, M Guest, R M Greenhalgh, A H Davies.   

Abstract

PURPOSE: We set out to assess the new Aberdeen Varicose Veins Questionnaire (Aberdeen Questionnaire) for the properties necessary for a valid measure of health outcome, to determine quality of life of patients with varicose veins, and to determine the effect of surgery on quality of life.
METHODS: A prospective consecutive cohort of 137 patients undergoing varicose vein surgery completed the self-administered SF-36 and Aberdeen Questionnaire and 25 questions relating to the symptoms and concerns of patients with varicose veins. Follow-up was done by repeated questionnaires 6 weeks after surgery. The Aberdeen Questionnaire was assessed for reliability, validity, responsiveness, and practicality. Quality of life of patients with varicose veins was compared with an age- and sex-matched sample of the general population.
RESULTS: Reliability estimates for the 8 scales short-form health survey (SF-36) and the Aberdeen Questionnaire were all above 0.7 (Cronbach's alpha). The Aberdeen Questionnaire had a highly significant correlation (r = 0. 74, P <.0001) with the patients' symptoms and concerns questionnaire, which is evidence of its validity. Patients with varicose veins score lower than United Kingdom norms (P <.001) in the physical domains of the SF-36, indicating worse health. After surgery, the SF-36 scores improved in all 8 domains of health, reaching significance in "Mental Health" (P <.05) and approaching significance in "General Health" (P =.066). The Health Transition Item of the SF-36 and the Aberdeen Questionnaire both showed a highly significant improvement in health (P <.001).
CONCLUSION: The Aberdeen Questionnaire is a valid measure of quality of life for patients with varicose veins. Persons with varicose veins have a reduced quality of life compared with the general population, and this discrepancy is significantly improved at 6 weeks by operating on them.

Entities:  

Mesh:

Year:  1999        PMID: 10514210     DOI: 10.1016/s0741-5214(99)70110-2

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  27 in total

1.  Positive Outcomes of Varicose Vein Surgery: The Patient Perspective.

Authors:  Wei-Han Cheng; Haridarshan Patel; Wan-Ju Lee; Fang-Ju Lin; A Simon Pickard
Journal:  Patient       Date:  2015-08       Impact factor: 3.883

2.  Patient-reported quality-of-life after radiofrequency ablation of varicose veins compared to conventional surgery.

Authors:  R Thompson; A Lewis; C Weir
Journal:  Ir J Med Sci       Date:  2013-03-30       Impact factor: 1.568

3.  Retrospective comparison of clinical outcomes between endovenous laser and saphenous vein-sparing surgery for treatment of varicose veins.

Authors:  Chih-Yang Chan; Tzu-Chun Chen; Yung-Kun Hsieh; Jih-Hsin Huang
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

4.  Pain Outcomes Following Mechanochemical Ablation vs Cyanoacrylate Adhesive for the Treatment of Primary Truncal Saphenous Vein Incompetence: The MOCCA Randomized Clinical Trial.

Authors:  Amjad Belramman; Roshan Bootun; Tjun Yip Tang; Tristan R A Lane; Alun H Davies
Journal:  JAMA Surg       Date:  2022-05-01       Impact factor: 16.681

5.  Current treatment of varicose veins.

Authors:  François Becker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

6.  A study of the routine use of venous photoplethysmography in a one-stop vascular surgery clinic.

Authors:  S Beraldo; A Satpathy; S R Dodds
Journal:  Ann R Coll Surg Engl       Date:  2007-05       Impact factor: 1.891

7.  Quality of life in patients with chronic venous disease in Turkey: influence of different treatment modalities at 6-month follow-up.

Authors:  Kadir Çeviker; Şahin Şahinalp; Erdinç Çiçek; Deniz Demir; Dinçer Uysal; Rasih Yazkan; Abdullah Akpınar; Turhan Yavuz
Journal:  Qual Life Res       Date:  2015-11-13       Impact factor: 4.147

8.  Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease.

Authors:  Rashad Carlton; Rajiv Mallick; Chelsey Campbell; Aditya Raju; Thomas O'Donnell; Michael Eaddy
Journal:  Am Health Drug Benefits       Date:  2015-10

9.  Outcomes after truncal ablation with or without concomitant phlebectomy for isolated symptomatic varicose veins (C2 disease).

Authors:  Craig S Brown; Andrea T Obi; Jack L Cronenwett; Lowell Kabnick; Thomas W Wakefield; Nicholas H Osborne
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-06-02

10.  Comparison of unilateral vs bilateral and staged bilateral vs concurrent bilateral truncal endovenous ablation in the Vascular Quality Initiative.

Authors:  Craig S Brown; Nicholas H Osborne; Gloria Y Kim; Danielle C Sutzko; Thomas W Wakefield; Andrea T Obi; Issam Koleilat
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.